Toronto Dominion Bank’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Toronto Dominion Bank’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-811	Closed	–	–	1949
2023 Q2	$0	Buy	+811	New	+$245	﹤0.01%	1906
2022 Q1	–	Sell	-104,086	Closed	-$1.03M	–	2164
2021 Q4	$1.03M	Hold	104,086	–	–	﹤0.01%	1009
2021 Q3	$1.03M	Hold	104,086	–	–	﹤0.01%	886
2021 Q2	$1.02M	Buy	+104,086	New	+$1.01M	﹤0.01%	877

Toronto Dominion Bank's GRNA Position: Q3 2023 in Review

Toronto Dominion Bank sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 811 shares.

Toronto Dominion Bank first reported a position in GRNA in Q2 2021 and held it in 4 quarters. The position peaked at $1.03M in Q4 2021. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Toronto Dominion Bank reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Toronto Dominion Bank sold 811 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023.
Toronto Dominion Bank first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2021 and held it in 4 quarters.
Toronto Dominion Bank's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $1.03M in Q4 2021.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Toronto Dominion Bank's 13F filing for Q3 2023, filed 14 Nov 2023.